| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 03/23/2005 | CN1599737A Ring fused pyrazole derivatives |
| 03/23/2005 | CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists |
| 03/23/2005 | CN1599722A 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 03/23/2005 | CN1599613A Combinations for the treatment of immunoinflammatory disorders |
| 03/23/2005 | CN1599607A Carbinols for the treatment of neuropathic dysfunction |
| 03/23/2005 | CN1194086C Preparing method method of neural stem cell preparation, |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/23/2005 | CN1193746C Substituted nitrobenzene derimative for medicine and other use |
| 03/22/2005 | US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer |
| 03/22/2005 | US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents |
| 03/17/2005 | WO2005023252A1 Method of increasing the extent of absorption of tizanidine by combined intake with food |
| 03/17/2005 | WO2004113305A3 Diamino substituted quinazoline derivatives as promoters of smn2 |
| 03/17/2005 | WO2003043619A8 New use for the treatment of gastroesophageal reflux disease |
| 03/17/2005 | WO2003037887A8 Therapeutic isoquinoline compounds |
| 03/17/2005 | WO2002050028A8 Substituted benzoindoles as spla2 inhibitors |
| 03/17/2005 | US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors |
| 03/17/2005 | US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 03/17/2005 | US20050059144 MHC class II antigen-presenting systems and methods for activating CD4+ T cells |
| 03/17/2005 | US20050059093 Method for detecting modulators of Notch signalling |
| 03/17/2005 | US20050059081 Dipeptidyl peptidase IV (DPPIV); homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders; antibodies for therapeutic or diagnostic use; host cells |
| 03/17/2005 | US20050058633 Stem cells that transform to beating cardiomyocytes |
| 03/16/2005 | EP1514556A1 Botulinum toxin pharmaceutical compositions |
| 03/16/2005 | EP1514539A2 Micro-encapsulated topical analgesic for pain relief and sleeve comprising it |
| 03/16/2005 | EP1513839A1 3-substituted quinuclidines and their use |
| 03/16/2005 | EP1513837A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 03/16/2005 | EP1513821A1 Protein kinase inhibitors |
| 03/16/2005 | EP1513809A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders |
| 03/16/2005 | EP1513529A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 03/16/2005 | EP1513516A1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS ANDPROCESSES FOR PREPARING AND THEIR USES |
| 03/16/2005 | EP1513404A1 Intramyocardial injection of autologous bone marrow |
| 03/16/2005 | EP1392699B1 6h-oxazolo 4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 03/16/2005 | EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/16/2005 | EP0854724B1 Method of treating the navicular disease in horses |
| 03/16/2005 | CN1596263A Aryl fused azapolycyclic compounds |
| 03/16/2005 | CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 03/16/2005 | CN1596249A Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them |
| 03/16/2005 | CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer |
| 03/16/2005 | CN1596112A Benzothiazole derivatives |
| 03/16/2005 | CN1593639A Chinese medicine decoction for treating flaccidity syndrome |
| 03/15/2005 | US6867222 Nociceptin analogs |
| 03/15/2005 | CA2246595C Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones |
| 03/10/2005 | WO2004081040A3 Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications |
| 03/10/2005 | US20050054674 Activator of peroxisome proliferator-activated receptor |
| 03/10/2005 | US20050054624 Administering steroid9such as estrogen) containing hydrophobic substitution such as adamamtane ring; Alzheimer's, Parkinson's, Huntington's disease; multiple sclerosis; amyotropic lateral sclerosis; stroke; antiischemic agents |
| 03/10/2005 | US20050054623 Transdermal supplying testosterone gel |
| 03/10/2005 | US20050054593 New drug |
| 03/10/2005 | US20050054090 MHC class II antigen-presenting systems and methods for activating CD4cells |
| 03/09/2005 | EP1512688A1 Use of K-252a derivatives for the treatment of Parkinson's disease |
| 03/09/2005 | EP1512411A1 Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 03/09/2005 | EP1512400A1 Treatment of neurodegenerative diseases |
| 03/09/2005 | EP1511744A2 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 03/09/2005 | EP1511742A1 Kinase inhibitors |
| 03/09/2005 | EP1511737A1 Aryloximes |
| 03/09/2005 | EP1511736A1 Therapeutic molecules and methods-1 |
| 03/09/2005 | EP1511726A1 Method for preparing 1,3,5-triaminobenzene and hydrolyzing it into high-purity phloroglucinol |
| 03/09/2005 | EP1511499A2 Immunomodulatory compounds and methods of use thereof |
| 03/09/2005 | EP1511483A2 Methods of treatment with lxr modulators |
| 03/09/2005 | EP1511473A2 Bis-aromatic alkanols |
| 03/09/2005 | EP1140112B1 Etherlysophospholipids for the treatment of chronic inflammatory diseases |
| 03/09/2005 | CN1592645A Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory anti-body combination |
| 03/09/2005 | CN1590379A New heterocyclic oxime compounds, preparing process and medical composition thereof |
| 03/09/2005 | CN1590373A Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol |
| 03/09/2005 | CN1192022C Novel compound |
| 03/08/2005 | US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases |
| 03/08/2005 | US6864355 Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain |
| 03/08/2005 | US6864277 Brain diosrders; cardiovascular disorders; central nervous system disorders; psychological disorders |
| 03/08/2005 | US6864266 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists |
| 03/08/2005 | US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy |
| 03/08/2005 | US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer |
| 03/08/2005 | US6864248 Androgenic steroid compounds and a method of making and using the same |
| 03/03/2005 | US20050049424 6-Hydroxy isoflavones derivatives and medicaments involving same |
| 03/03/2005 | US20050049292 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression |
| 03/03/2005 | US20050049258 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 03/03/2005 | US20050049251 Inhibitors of p38 |
| 03/03/2005 | US20050049250 7-Aikyl and cycloalkyl-substituted imidazotriazinones |
| 03/03/2005 | US20050049234 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents |
| 03/03/2005 | US20050049233 Transdermal administering of testosterone |
| 03/03/2005 | US20050048639 Caspase-8 binding protein, its preparation and use |
| 03/03/2005 | US20050048537 Novel human lipocalin homologs and polynucleotides encoding the same |
| 03/03/2005 | US20050048488 Expression vector comprising nucleotide sequences coding excitatory amino acid transporter 2 (EAAT2) proteins for use in identifying modulator for treatment and preention of neurological or psychiatric disorder |
| 03/03/2005 | US20050048479 Adenylyl and guanylyl cyclases |
| 03/03/2005 | US20050048066 Identification of potential immunodominant acetylcholine receptor alpha subunit |
| 03/03/2005 | US20050048055 Use of CD40 engagement to alter T cell receptor usage |
| 03/03/2005 | US20050048039 Administering exogenous monocyte cells loaded with corrective agent; chemotactic factor for macrophages; diagnosis of bone disorders, anticarcinogenic agents, rheumatic disorders; Alzheimer's disease; Parkinson's disease; Huntington's disease; multiple sclerosis; stroke |
| 03/03/2005 | US20050048035 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| 03/03/2005 | US20050048034 Using adipose stem cells to treat ischemic ulcer, diabetic and traumatic wounds; regenerative medicine |
| 03/03/2005 | US20050047958 Methods for sterilizing preparations of digestive enzymes |
| 03/02/2005 | EP1510516A1 Pyrazole compound and medicinal composition containing the same |
| 03/02/2005 | EP1509621A1 Treatment with cytokines for alzheimer's disease |
| 03/02/2005 | EP1509526A2 Imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof |
| 03/02/2005 | EP1509506A1 Pyridazine derivatives |
| 03/02/2005 | EP1509489A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/02/2005 | EP1509251A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/02/2005 | EP1509233A1 Liquid formulation of decitabine and use of the same |
| 03/02/2005 | EP1509217A1 Monotherapy for the treatment of amyotrophic lateral sclerosis with cyclooxygenase-2 (cox 2) inhibitor(s) |
| 03/02/2005 | CN1589271A Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function |
| 03/02/2005 | CN1589258A Novel beta -phenyl- alpha -oxysubstituted propionic derivatives: process for their preparation and their use in the preparation of pharmaceutically important compounds |
| 03/02/2005 | CN1589148A Succinic acid salts of 5, 8, 14-triazatetracyclo'10.3.1.0 less than2, 11greater than.0 less than 4, 9 greater than-hexadeca-2(11), 3, 5, 7, 9-pentaene and pharmaceutical compositions thereof |
| 03/02/2005 | CN1589146A Benzothiazole derivatives as adenosine receptor ligands |
| 03/02/2005 | CN1191236C Substituted 6,6-Hetero-dicycloderivative |